These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Structural domains of Porphyromonas gingivalis recombinant fimbrillin that mediate binding to salivary proline-rich protein and statherin. Amano A; Sharma A; Lee JY; Sojar HT; Raj PA; Genco RJ Infect Immun; 1996 May; 64(5):1631-7. PubMed ID: 8613371 [TBL] [Abstract][Full Text] [Related]
6. Binding of Porphyromonas gingivalis fimbriae to proline-rich glycoproteins in parotid saliva via a domain shared by major salivary components. Amano A; Shizukuishi S; Horie H; Kimura S; Morisaki I; Hamada S Infect Immun; 1998 May; 66(5):2072-7. PubMed ID: 9573091 [TBL] [Abstract][Full Text] [Related]
7. Active sites of salivary proline-rich protein for binding to Porphyromonas gingivalis fimbriae. Kataoka K; Amano A; Kuboniwa M; Horie H; Nagata H; Shizukuishi S Infect Immun; 1997 Aug; 65(8):3159-64. PubMed ID: 9234769 [TBL] [Abstract][Full Text] [Related]
8. The nasal dendritic cell-targeting Flt3 ligand as a safe adjuvant elicits effective protection against fatal pneumococcal pneumonia. Kataoka K; Fujihashi K; Oma K; Fukuyama Y; Hollingshead SK; Sekine S; Kawabata S; Ito HO; Briles DE; Oishi K Infect Immun; 2011 Jul; 79(7):2819-28. PubMed ID: 21536790 [TBL] [Abstract][Full Text] [Related]
9. Nasal immunization with the 40-kDa outer membrane protein of Porphyromonas gingivalis plus cholera toxin induces protective immunity in aged mice. Cai Y; Kurita-Ochiai T; Kobayashi R; Hashizume T; Yamamoto M J Oral Sci; 2013; 55(2):107-14. PubMed ID: 23748449 [TBL] [Abstract][Full Text] [Related]
10. [Studies on the induction of the humoral immune responses to Bacteroides gingivalis fimbrial antigen in mice]. Shimauchi H Osaka Daigaku Shigaku Zasshi; 1990 Jun; 35(1):60-77. PubMed ID: 1983739 [TBL] [Abstract][Full Text] [Related]
11. A combination of Flt3 ligand cDNA and CpG oligodeoxynucleotide as nasal adjuvant elicits protective secretory-IgA immunity to Streptococcus pneumoniae in aged mice. Fukuyama Y; King JD; Kataoka K; Kobayashi R; Gilbert RS; Hollingshead SK; Briles DE; Fujihashi K J Immunol; 2011 Feb; 186(4):2454-61. PubMed ID: 21242514 [TBL] [Abstract][Full Text] [Related]
12. Construction of a sIgA-enhancing anti-Porphyromonas gingivalis FimA vaccine and nasal immunization in mice. Guo H; Wang X; Jiang G; Yang P Immunol Lett; 2006 Sep; 107(1):71-5. PubMed ID: 16959327 [TBL] [Abstract][Full Text] [Related]
13. Sublingual immunization with recombinant GroEL plus CpG-ODN inhibits Porphyromonas gingivalis-induced inflammation and alveolar bone loss. Chang E; Kobayashi R; Hagiwara-Hamano M; Kurita-Ochiai T; Komiya M Mol Oral Microbiol; 2022 Apr; 37(2):31-41. PubMed ID: 34921516 [TBL] [Abstract][Full Text] [Related]
14. Role of the carboxyl-terminal region of Porphyromonas gingivalis fimbrillin in binding to salivary proteins. Nagata H; Sharma A; Sojar HT; Amano A; Levine MJ; Genco RJ Infect Immun; 1997 Feb; 65(2):422-7. PubMed ID: 9009291 [TBL] [Abstract][Full Text] [Related]
15. Generation of specific antibody-secreting cells in salivary glands of BALB/c mice following parenteral or oral immunization with Porphyromonas gingivalis fimbriae. Kusumoto Y; Ogawa T; Hamada S Arch Oral Biol; 1993 May; 38(5):361-7. PubMed ID: 8101076 [TBL] [Abstract][Full Text] [Related]
16. Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen. Boyaka PN; Tafaro A; Fischer R; Leppla SH; Fujihashi K; McGhee JR J Immunol; 2003 Jun; 170(11):5636-43. PubMed ID: 12759444 [TBL] [Abstract][Full Text] [Related]
17. Mucosal vaccination shapes the expression of salivary antibodies and establishment of CD8+ T-cells. Polak D; Benzki-Namdar E; Houri-Haddad Y; Shapira L J Periodontol; 2014 Jul; 85(7):991-7. PubMed ID: 24359165 [TBL] [Abstract][Full Text] [Related]
18. Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit. Takahashi Y; Kumada H; Hamada N; Haishima Y; Ozono S; Isaka M; Yasuda Y; Tochikubo K; Umemoto T Oral Microbiol Immunol; 2007 Dec; 22(6):374-80. PubMed ID: 17949339 [TBL] [Abstract][Full Text] [Related]
19. Targeted salivary gland immunization with plasmid DNA elicits specific salivary immunoglobulin A and G antibodies and serum immunoglobulin G antibodies in mice. Kawabata S; Terao Y; Fujiwara T; Nakagawa I; Hamada S Infect Immun; 1999 Nov; 67(11):5863-8. PubMed ID: 10531241 [TBL] [Abstract][Full Text] [Related]
20. Mucosal immune features to phosphorylcholine by nasal Flt3 ligand cDNA-based vaccination. Baatarjav T; Kataoka K; Gilbert RS; Terao Y; Fukui M; Goto M; Kawabata S; Yamamoto M; Fujihashi K; Ito HO Vaccine; 2011 Aug; 29(34):5747-57. PubMed ID: 21683111 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]